Gorlin syndrome Clinical Trials Gorlin syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (SEB) in Gorlin Syndrome Patients
Condition:   Basal Cell Nevus SyndromeInterventions:   Drug: patidegib;   Drug: vehicle gelSponsor:   PellePharm, Inc.Recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2016 Category: Research Source Type: clinical trials